Survival Outcomes in Hepatocellular Carcinoma: A Decade of Treatment in a Western Tertiary Referral Center

This publication has 28 references indexed in Scilit:

• Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System
  JAMA Network Open, 2024
• Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model—a Western European multicenter study
  Updates in Surgery, 2023
• Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
• A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
  European Journal of Nuclear Medicine and Molecular Imaging, 2022
• Global, regional and national burden of primary liver cancer by subtype
  European Journal of Cancer, 2022
• BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
  Journal of Hepatology, 2021
• Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
  Hepatology, 2021
• Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
  Journal of Cancer Research and Clinical Oncology, 2021
• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
  Journal of Hepatology, 2018
• Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma
  CardioVascular and Interventional Radiology, 2014